The interdepartmental CURE: Digestive Diseases Research Core Center (CURE: DDRCC), funded continuously since 1989, is composed of 68 members and 26 associate members comprising a multidisciplinary group of physicians and basic scientists with strong independent peer-reviewed grant-supported programs in basic, translational and clinical research of the digestive system. Annual direct digestive diseases-related grant support for the research base is $16,858,584 including $6,089,729 from NIDDK. The current programs of this Research Base can be broadly divided in three major and interrelated complementary areas: A) Molecular and integrative mechanisms of gastrointestinal and pancreatic physiology and inflammation; B) Bidirectional brain-gut interactions and functional disorders of the digestive system; C) Mechanism of action of neuro-hormonal Gl signals: receptor regulation, signal transduction and control of normal and abnormal cell proliferation. The Biomedical Research Cores outlined in this proposal provide ready access to technologies and to clinical and biological materials that are essential to the programs of center members. These Cores offer access to modern cellular imaging to study signaling proteins and their functions, facilitate intestinal stem cell biology, provide animal models and techniques for studying integrative physiology and pathophysiology, molecular vectors to express a wide variety of proteins and access to a broad range of techniques and patients for clinical studies. The Administrative Core gives a wide range of administrative support for members and for center activities, including a comprehensive and multidisciplinary enrichment program. The Pilot and Feasibility Study program has provided a very successful mechanism for promoting the development of new programs and ideas in digestive diseases related research, primarily by young investigators. The CURE: DDRCC, enhanced by substantial direct institutional support, provides a forum, strategic vision and programmatic integration in which faculty members can advance the understanding of fundamental mechanisms relating to the function, disorders and diseases of the digestive system by making their combined efforts much greater than the sum of the parts.

Public Health Relevance

The CURE DRRCC comprises a multidisciplinary research base dedicated to advancing our understanding of the biology, functional disorders and diseases of the digestive system. Scientific core facilities, Pilot and Feasibility Study awards an enrichment programs provide a platform of novel technologies, services and interactions to promote the collaborative research efforts of the CURE: DDRCC membership.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK041301-29
Application #
9392150
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Perrin, Peter J
Project Start
1996-12-01
Project End
2019-11-30
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
29
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Chang, Hui-Hua; Moro, Aune; Chou, Caroline Ei Ne et al. (2018) Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-induced Obesity in the Conditional KrasG12D Mouse Model. Sci Rep 8:5899
Pan, David Z; Garske, Kristina M; Alvarez, Marcus et al. (2018) Integration of human adipocyte chromosomal interactions with adipose gene expression prioritizes obesity-related genes from GWAS. Nat Commun 9:1512
Fang, Kai; Law, Ivy Ka Man; Padua, David et al. (2018) MicroRNA-31-3p Is Involved in Substance P (SP)-Associated Inflammation in Human Colonic Epithelial Cells and Experimental Colitis. Am J Pathol 188:586-599
Yakabi, Seiichi; Wang, Lixin; Karasawa, Hiroshi et al. (2018) VIP is involved in peripheral CRF-induced stimulation of propulsive colonic motor function and diarrhea in male rats. Am J Physiol Gastrointest Liver Physiol 314:G610-G622
Henström, Maria; Diekmann, Lena; Bonfiglio, Ferdinando et al. (2018) Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome. Gut 67:263-270
Soroosh, Artin; Koutsioumpa, Marina; Pothoulakis, Charalabos et al. (2018) Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 314:G256-G262
Aschemeyer, Sharraya; Qiao, Bo; Stefanova, Deborah et al. (2018) Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Blood 131:899-910
Kaji, I; Akiba, Y; Furuyama, T et al. (2018) Free fatty acid receptor 3 activation suppresses neurogenic motility in rat proximal colon. Neurogastroenterol Motil 30:
Kim, Paul H; Luu, Jennings; Heizer, Patrick et al. (2018) Disrupting the LINC complex in smooth muscle cells reduces aortic disease in a mouse model of Hutchinson-Gilford progeria syndrome. Sci Transl Med 10:
Dong, Tien S; Aby, Elizabeth S; Benhammou, Jihane N et al. (2018) Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c. World J Hepatol 10:612-621

Showing the most recent 10 out of 1097 publications